Literature DB >> 3834833

In vitro interaction of aminoglycosides with beta-lactam penicillins.

S M Wallace, L Y Chan.   

Abstract

The aminoglycosides are used clinically in combination with beta-lactam antibiotics. The combined use, however, produces an interaction and inactivation of the antibiotics. A study was designed to investigate the kinetics of the interaction in vitro. Four concentrations of aminoglycosides (5 to 20 micrograms of gentamicin and tobramycin per ml) and penicillins (100 to 600 micrograms of carbenicillin and ticarcillin per ml) were incubated in plasma (3 days, 37 degrees C). Samples taken at 12-h intervals were analyzed for both aminoglycosides (radioimmunoassay) and penicillin (high-pressure liquid chromatography). In controls, degradation of all four antibiotics were by first-order reactions. In incubation mixtures of two antibiotics, the rate of loss of the aminoglycosides was greater than that in the controls, whereas the rate of loss of penicillins was not significantly increased. The loss of penicillins in incubation mixtures still appeared to be by first-order reactions. However, semilogarithmic plots of aminoglycoside concentrations were curvilinear, suggesting a second-order reaction. Aminoglycoside concentrations in incubation mixtures were fitted by computer to a model incorporating a second-order interaction between aminoglycosides and penicillins and the first-order loss of penicillin from the mixture. The interaction rate constant averaged 2.2 X 10(-4) (micrograms/ml h)-1 for interaction of both carbenicillin and ticarcillin with gentamicin and 1.6 X 10(-4) (micrograms/ml h)-1 for interaction of the penicillins with tobramycin. The effect of the interaction in vivo was examined by computer simulation using the kinetic parameters determined in vitro.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3834833      PMCID: PMC180231          DOI: 10.1128/AAC.28.2.274

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Inactivation of gentamicin by penicillins in patients with renal failure.

Authors:  F R Ervin; W E Bullock; C E Nuttall
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

2.  Interactions between aminoglycoside antibiotics and carbenicillin or ticarillin.

Authors:  H A Holt; J M Broughall; M McCarthy; D S Reeves
Journal:  Infection       Date:  1976       Impact factor: 3.553

3.  Stability of gentamicin in serum.

Authors:  S M Jones; D J Blazevic; H H Balfour
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

4.  Carbenicillin inactivation of aminoglycosides in patients with severe renal failure.

Authors:  R Weibert; W Keane; F Shapiro
Journal:  Trans Am Soc Artif Intern Organs       Date:  1976

5.  Ticarcillin vs carbenicillin: clinical pharmacokinetics.

Authors:  R D Libke; J T Clarke; E D Ralph; R P Luthy; W M Kirby
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

6.  In vitro evaluation of tobramycin, a new aminoglycoside antibiotic.

Authors:  M E Levison; R Knight; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

Review 7.  Gentamicin in 1978.

Authors:  G B Appel; H C Neu
Journal:  Ann Intern Med       Date:  1978-10       Impact factor: 25.391

8.  Inactivation of netilmicin by carbenicillin.

Authors:  D J Flournoy
Journal:  Infection       Date:  1978       Impact factor: 3.553

9.  Gentamicin and ticarcillin serum levels.

Authors:  J Murillo; H C Standiford; S C Schimpff; B A Tatem
Journal:  JAMA       Date:  1979-06-01       Impact factor: 56.272

10.  Effect of time and concentration upon interaction between gentamicin, tobramycin, Netilmicin, or amikacin and carbenicillin or ticarcillin.

Authors:  L K Pickering; P Gearhart
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

View more
  8 in total

1.  Activity of cefotiam in combination with beta-lactam antibiotics on enterobacterial hospital strains.

Authors:  R Vanhoof; J M Hubrechts; H J Nyssen; E Nulens; J Leger; N de Schepper; E Kupperberg; M L Couvreur
Journal:  Pharm Weekbl Sci       Date:  1990-06-22

2.  Pharmacokinetics of regional limb perfusion using a combination of amikacin and penicillin in standing horses.

Authors:  Roee Dahan; Gil L Oreff; Amos J Tatz; Tal Raz; Malka Britzi; Gal Kelmer
Journal:  Can Vet J       Date:  2019-03       Impact factor: 1.008

Review 3.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

4.  Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal disease.

Authors:  C E Halstenson; C A Hirata; K L Heim-Duthoy; P A Abraham; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

5.  Pharmacokinetics of a combination of amikacin sulfate and penicillin G sodium for intravenous regional limb perfusion in adult horses.

Authors:  Jorge E Nieto; Jan Trela; Scott D Stanley; Sawsan Yamout; Jack R Snyder
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

6.  Role of sodium in protection by extended-spectrum penicillins against tobramycin-induced nephrotoxicity.

Authors:  R Sabra; R A Branch
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

7.  In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.

Authors:  P C Fuchs; S Stickel; P H Anderson; A L Barry; S Shilling
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

8.  AZDAST the new horizon in antimicrobial synergism detection.

Authors:  Navid Ziaei-Darounkalaei; Mehrdad Ameri; Taghi Zahraei-Salehi; Omid Ziaei-Darounkalaei; Tahereh Mohajer-Tabrizi; Lotfollah Bornaei
Journal:  MethodsX       Date:  2016-01-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.